Categories

The Public Market Health IT Landscape

The Public Market Health IT Landscape

April 26, 2018

The public markets for Health IT have been unusually quiet in recent years.  Despite record setting private equity investment, the number of publicly-listed Health IT companies is contracting as the rate of IPOs is outpaced by go-privates and acquisitions.  During the period since 2016, no single Health IT company listed on a US exchange.  Several marquee Health IT companies have been acquired or…

Read More
HGP Releases its Year-End Health IT Market Review

HGP Releases its Year-End Health IT Market Review

January 24, 2018

Healthcare Growth Partners is pleased to release its Semi-Annual Health IT Market Review.  Our semi-annual report summarizes M&A and capital raising activity across health IT, health information services, and digital health.  This edition of the report includes a discussion and analysis of the sustainability of Health IT funding rates and our bi-annual Health IT Corporate M&A Survey findings as…

Read More
Genomic Technologies See Strong Investment in 2017

Genomic Technologies See Strong Investment in 2017

November 07, 2017

In 1990, The Human Genome Project undertook the ambitious goal of mapping and sequencing the entire human genome. With over $3 billion in funding, the project took 13 years and was completed in 2003. Since then the cost of genome sequencing has fallen to a mere $1,000 and continues to…

Read More
Health IT Investment on Record Pace through Q3

Health IT Investment on Record Pace through Q3

October 24, 2017

Through Q3-2017, investment in Health Information Technology & Services (HIT) remains vibrant and on record pace.  HGP monitored 492 HIT investment transactions through Q3, representing 312 US and 180 non-US targets.  While the pace of activity in the US grew at a 19% annual rate over the last 6-years, non-US HIT investing increased at a dramatic 47% rate.  As striking as the deal volume increase…

Read More